The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Hepatic artery infusion chemotherapy (HAIC) combined with tislelizumab and lenvatinib for initial unresectable hepatocellular carcinoma (HCC) with portal vein tumor thrombus: A prospective, single-arm phase II trial.
 
Long Pan
No Relationships to Disclose
 
Ruirui Sun
No Relationships to Disclose
 
Qiang He
No Relationships to Disclose
 
Yin Zhou
No Relationships to Disclose
 
Jiachu Li
No Relationships to Disclose
 
Yang Gou
No Relationships to Disclose
 
Chenrui Wu
No Relationships to Disclose
 
Zixuan Fu
No Relationships to Disclose
 
Yaowu Zhao
No Relationships to Disclose
 
Qin He
No Relationships to Disclose
 
Ping Huang
No Relationships to Disclose